awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47321307-812868D8-DF0E-416B-B102-7CE9C953BEC0
Q47321307-812868D8-DF0E-416B-B102-7CE9C953BEC0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47321307-812868D8-DF0E-416B-B102-7CE9C953BEC0
A retrospective clinical audit of general practices in Australia to determine the motivation for switch to dolutegravir/abacavir/lamivudine and clinical outcomes.
P2860
Q47321307-812868D8-DF0E-416B-B102-7CE9C953BEC0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47321307-812868D8-DF0E-416B-B102-7CE9C953BEC0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
17e80ab9720125f6ccb3c40690d3d7aa8b9df51c
P2860
Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week res